Results 101 to 110 of about 24,222 (188)

Thiazole-conjugated covalent organic framework membranes enable ultraselective molecular desalination under strongly acidic conditions. [PDF]

Nat Commun
Liao Y, Fang S, Tang J, Tang M, Zheng F, Pan Z, Zhan J, Han G.   +7 more
europepmc   +1 more source

Erratum: 2-(3-(4-Bromophenyl)-5-{3-[5-methyl-1-(4-methylphenyl)-1<i>H</i>-1,2,3-triazol-4-yl]-1-phenyl-1<i>H</i>-pyrazol-4-yl}-4,5-dihydro-1<i>H</i>-pyrazol-1-yl)-4-(4-chlorophenyl)-1,3-thiazole. Corrigendum. [PDF]

IUCrdata
El-Hiti GA, Abdel-Wahab BF, Khidre RE, Mostafa MS, Hegazy AS, Kariuki BM.   +5 more
europepmc   +1 more source

Synthesis of some new pyrene-based hydrazinyl-thiazole derivatives <i>via</i> a one-pot strategy: biological evaluation and molecular docking studies. [PDF]

RSC Adv
Jawalepatil PD, Jadhav AM, Bhosale PB, Singh P, Choi HH, Nam SY, Waman MN, Wadje GN, Deshmukh SU.   +8 more
europepmc   +1 more source

Investigation of Potent Anti-<i>Mycobacterium tuberculosis</i> Agents Derived from Pyridine Derivatives Targeting the Enoyl Acyl Carrier Protein Reductase (InhA): Design, Synthesis, and Computational Analysis. [PDF]

Drug Des Devel Ther
Sabt A, Korycka-Machala M, Kassem AF, The Son N, Ha NX, Brzostek A, Thabit MG, Kawka M, Dziadek B, Elshamy AI, Atwa AM, Dziadek J.   +11 more
europepmc   +1 more source

Design, synthesis, and molecular modeling of novel thiazolopyridine-based inhibitors of enoyl acyl carrier protein reductase (InhA) as anti-<i>Mycobacterium tuberculosis</i> agents. [PDF]

RSC Med Chem
Sabt A, Korycka-Machała M, Kassem AF, Saleh AM, Farag H, Shaldam MA, Thabit MG, Brzostek A, Kuzioła M, Dziadek B, Ibrahim HAA, Lei X, Dziadek J, Abdelrahman MA.   +13 more
europepmc   +1 more source

<i>N</i>-Cyano sulfoximine-mediated thiazole ligation with <i>N</i>-terminal cysteine under mild aqueous conditions. [PDF]

RSC Med Chem
Kim E, Hyun JY, Song JH, Lim HJ, Lim HJ, Park SJ.   +5 more
europepmc   +1 more source

Molecular Hybridization of Naphthoquinones and Thiazoles: A Promising Strategy for Anticancer Drug Discovery. [PDF]

Pharmaceuticals (Basel)
de Moraes LGC, Santos TB, da Rocha DR.
europepmc   +1 more source

Thiazole-driven heterocyclic hybrids as EGFR inhibitors: progress in synthesis and anticancer applications. [PDF]

RSC Adv
Dsouza A, Subrahmanyam VM, Shetty NS.
europepmc   +1 more source

Fragment-Based Development of NSP14 Exonuclease Inhibitors Confounded by Batch-to-Batch Variability. [PDF]

ACS Chem Biol
Coker JA, Sun R, Polzer PM, Romigh T, Goins CM, Wang NS, Jung JU, Stauffer SR.   +7 more
europepmc   +1 more source

A Rigid Polymer Donor Based on a Simple Benzodithiophene-Thiazole Backbone for Organic Photovoltaics. [PDF]

ChemSusChem
Teshima Y, Yamanaka K, Sato Y, Jeon J, Saito M, Mikie T, Kim HD, Ohkita H, Osaka I.   +8 more
europepmc   +1 more source